Inventia Healthcare Limited Lansoprazole Export Data — India (DGFT 2022–2026)

Name: Inventia Healthcare Limited Lansoprazole Export Records India — #13 Exporter, 55 Shipments, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lansoprazole

India Pharmaceutical Trade Intelligence

$290.2M316 Suppliers105 CountriesHS 30049034

ExportsIndia → CANADA54.9%India → UNITED STATES20.7%

ImportsISRAEL → India$8.3M UNITED STATES → India$178.0K

#1 Supplier: SANDOZ PRIVATE #1 Buyer: SANDOZ CANADA

Inventia Healthcare Limited — Lansoprazole Exporter #13 | $1.9M Trade Value | TransData Nexus | TransData Nexus

Inventia Healthcare Limited — Lansoprazole Exporter Profile

Indian Pharmaceutical Exporter · #13 for Lansoprazole · $1.9M export value · DGFT Verified

Inventia Healthcare Limited is the #13 Indian exporter of Lansoprazole with $1.9M in export value and 55 verified shipments. Inventia Healthcare Limited holds a 0.6% market share in Lansoprazole exports across 2 countries. The company exports 11 pharmaceutical products worth $36.5M across 6 therapeutic categories.

Inventia Healthcare Limited — Lansoprazole Export Profile: Buyers & Destinations

Inventia Healthcare Limited Lansoprazole export treemap — buyers and destination countries | TransData Nexus

Where Does Inventia Healthcare Limited Export Lansoprazole?

Country	Value	Shipments	Share
UNITED STATES	$1.6M	53	100.0%
CHINA	$107	2	0.0%

Inventia Healthcare Limited exports Lansoprazole to 2 countries. The largest destination is UNITED STATES accounting for 100.0% of Inventia Healthcare Limited's Lansoprazole shipments. These destinations reflect Inventia Healthcare Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Lansoprazole from Inventia Healthcare Limited?

What Lansoprazole Formulations Does Inventia Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
Lansoprazole DR Capsules 30mg 90 counts	$559.2K	13
Lansoprazole DR Capsules 30mg 500 counts	$439.3K	14
Lansoprazole DR Capsules 30mg 90 counts70756-807-90 33012 Bottles = Nos	$100.0K	2
Lansoprazole DR Capsules 15mg 30 counts	$84.4K	6
LANSOPRAZOLE DR CAPSULES 30MG 90 COUNTS(70756-807-90) (33392 BOTTLES = NOS)NOS	$77.3K	3
Lansoprazole DR Capsules 30mg 500 counts70756-807-51 2880 Bottles = Nos	$61.4K	2
Lansoprazole DR Capsules 30mg 90 counts70756-807-90 26804 Bottles = Nos	$50.0K	1
LANSOPRAZOLE DR CAPSULES 30MG 90 COUNTS(70756-807-90) (QTY IN 33624 BOTTLES)	$50.0K	1
Lansoprazole DR Capsules 30mg 90 counts70756-807-90 16644 Bottles = Nos	$39.3K	1
Lansoprazole DR Capsules 15mg 30 counts70756-806-30 18840 Bottles = Nos	$37.4K	2

Inventia Healthcare Limited exports 19 distinct Lansoprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Lansoprazole DR Capsules 30mg 90 counts with 13 shipments worth $559.2K.

How Does Inventia Healthcare Limited Compare to Nearest Lansoprazole Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	ZYDUS LIFESCIENCES LIMITED	$2.1M	43	3	$50.0K
12	ALKEM LABORATORIES LIMITED	$2.0M	40	2	$50.0K
13	INVENTIA HEALTHCARE LIMITED ★	$1.9M	55	2	$33.9K
4	LINCOLN PHARMACEUTICALS LTD	$1.7M	34	7	$50.0K
14	COMBITIC GLOBAL CAPLET PRIVATE LIMITED	$1.5M	152	2	$10.0K

Inventia Healthcare Limited ranks #13 among 316 Indian Lansoprazole exporters. Average shipment value of $33.9K compared to the market average of $227.0K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and ALKEM LABORATORIES LIMITED.

Which Indian Ports Ship Lansoprazole Exports?

Port	Shipments	% Share
SAHAR AIR	729	15.0%
DELHI AIR CARGO ACC (INDEL4)	577	11.9%
SAHAR AIR CARGO ACC (INBOM4)	416	8.5%
DELHI AIR	364	7.5%
NHAVA SHEVA SEA (INNSA1)	264	5.4%
JNPT/ NHAVA SHEVA SEA	209	4.3%
Bombay Air	140	2.9%
JNPT	106	2.2%

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Lansoprazole Exports

Inventia Healthcare's extensive export operations are currently navigating a complex geopolitical landscape that presents both challenges and opportunities. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management to mitigate potential delays and cost escalations. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The imposition of tariffs on a broad range of imports, including pharmaceuticals, has raised concerns about cost competitiveness and market access. Companies like Inventia must navigate these policy shifts by exploring alternative markets and enhancing operational efficiencies to maintain their competitive edge. (apnews.com)

Conversely, the European Union's stringent regulatory frameworks, such as the Falsified Medicines Directive, necessitate rigorous compliance measures. While these regulations impose additional operational requirements, they also present an opportunity for companies with robust quality systems to differentiate themselves. Inventia's adherence to international quality standards positions it favorably to meet these regulatory demands and strengthen its presence in the European market.

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency intensifying their focus on manufacturing practices and product quality. For Indian exporters, this translates into the necessity for stringent compliance with Good Manufacturing Practices (GMP) and other regulatory standards.

Inventia Healthcare's manufacturing facility in Ambernath and its research and development center in Thane are accredited by the U.S. FDA, U.K. MHRA, and other stringent regulatory authorities. This compliance underscores the company's commitment to maintaining high-quality standards, facilitating access to both emerging and regulated markets. (platinumequity.com)

However, the broader Indian pharmaceutical sector faces challenges related to quality assurance, with instances of regulatory non-compliance affecting the industry's reputation. To mitigate these risks, companies like Inventia must continually invest in quality control systems, employee training, and process improvements to ensure sustained compliance and market trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lansoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Inventia Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 55 individual customs records matching Inventia Healthcare Limited exporting Lansoprazole, covering 19 formulations to 2 countries via 4 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 105+ countries, 687+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lansoprazole

Lansoprazole

Inventia Healthcare Limited — Lansoprazole Exporter Profile

Inventia Healthcare Limited — Lansoprazole Export Profile: Buyers & Destinations

Where Does Inventia Healthcare Limited Export Lansoprazole?

Who Are the Top Buyers of Lansoprazole from Inventia Healthcare Limited?

What Is India's Total Lansoprazole Export Value and How Much Does Inventia Healthcare Limited Contribute?

What Is the Average Shipment Value for Inventia Healthcare Limited's Lansoprazole Exports?

How Does Inventia Healthcare Limited Compare to Other Indian Lansoprazole Exporters?

What Lansoprazole Formulations Does Inventia Healthcare Limited Export?

Regulatory Requirements: Exporting Lansoprazole to Key Markets

United States — FDA

How Does Inventia Healthcare Limited Compare to Nearest Lansoprazole Exporters?

Which Indian Ports Ship Lansoprazole Exports?

What Other Gastrointestinal Products Does Inventia Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Inventia Healthcare Limited's Lansoprazole Exports

Inventia Healthcare Limited — Regulatory Compliance & Quality Standards

About Inventia Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lansoprazole Export Data from Inventia Healthcare Limited

Lansoprazole Stats

Company Overview

Top Products by Inventia Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source

LIFE STAR PHARMA LLC.	UNITED STATES	$675.8K	19
LIFESTAR PHARMA LLC	UNITED STATES	$532.2K	19
LIFE STAR PHARMA LLC	UNITED STATES	$426.0K	15
GUANGZHOU BAIRUI MEDICINE CO LIMITED	CHINA	$107	2